STOCK TITAN

Augmedix - AUGX STOCK NEWS

Welcome to our dedicated page for Augmedix news (Ticker: AUGX), a resource for investors and traders seeking the latest updates and insights on Augmedix stock.

Augmedix (Nasdaq: AUGX) delivers AI-powered medical documentation solutions that transform clinician-patient conversations into structured EHR records. This page provides official updates on technological advancements, strategic partnerships, and operational milestones shaping the future of healthcare automation.

Access real-time updates on Augmedix's ambient AI innovations, including EHR integration developments, specialty-specific solution expansions, and collaborations with leading healthcare systems. Investors and healthcare professionals will find curated press releases, regulatory filings, and analyses of technology deployments across clinical settings.

Key content categories include product enhancement announcements, partnership disclosures with digital health platforms, financial performance updates, and clinical validation studies. All materials are sourced directly from company communications to ensure reliability.

Bookmark this page for streamlined access to Augmedix's latest developments in natural language processing applications and healthcare workflow optimization. Check regularly for insights into how AUGX continues reducing administrative burdens through intelligent documentation solutions.

Rhea-AI Summary
Augmedix (Nasdaq: AUGX) has been recognized as one of the World's Best Digital Health Companies 2024 by Newsweek and Statista Inc. The award highlights Augmedix's commitment to empowering clinicians through ambient AI medical documentation solutions. Augmedix's platform converts natural conversations into structured medical notes, enhancing efficiency and clinical decision-making. The company's inclusion in the top 400 companies from over 35 countries is based on financial performance, impact, and online engagement criteria.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
none
-
Rhea-AI Summary
Augmedix launches Augmedix Go, the industry’s first fully-automated, GenAI-powered medical documentation product for emergency departments. The product aims to improve patient experience, increase productivity, reduce cognitive burden, and shorten chart closure time. Augmedix Go was piloted with HCA Healthcare EDs, receiving positive feedback on note quality and AI accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
none
-
Rhea-AI Summary
Augmedix (AUGX) partners with Andor Health to enhance virtual care with ambient AI medical documentation, aiming to improve clinician-patient interactions and streamline workflows. The collaboration integrates AI-generated clinical notes within ThinkAndor® Virtual Visit, leveraging ambient documentation to transform care settings. Augmedix and Andor Health aim to optimize communication, reduce clinician burnout, and enhance patient outcomes through their innovative platforms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
Rhea-AI Summary
Augmedix (AUGX) partners with SADA, an Insight company, to accelerate digital health solutions and integrations. The collaboration aims to enhance ambient AI medical documentation and data products for health systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary
Augmedix (AUGX) reports impressive financial results for Q4 and full year 2023, showcasing revenue growth of 45% to $12.7 million and $44.9 million respectively. The company achieved a gross profit increase of 54% to $6.2 million and $21.5 million for the respective periods. Augmedix anticipates revenue of $60 to $62 million in 2024, reflecting strong growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.92%
Tags
none
-
Rhea-AI Summary
Augmedix (AUGX) announces positive data and product enhancements for Augmedix Go, saving clinicians up to 1 hour per day in medical documentation. The app supports over 50 medical specialties, generating real-time draft notes from natural conversations. Survey data shows 94% of clinicians report better patient focus. Augmedix Go integrates with major EHRs and uses AI models for high-quality notes. CEO Manny Krakaris emphasizes the need for automated solutions to combat administrative burden and burnout.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
AI
Rhea-AI Summary
Augmedix (Nasdaq: AUGX) to Release Q4 and Full Year 2023 Results on March 18, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
-
Rhea-AI Summary
Augmedix, Inc. (Nasdaq: AUGX) will participate in the Citizens JMP Technology Conference in San Francisco on March 4, 2024. The management team will host a fireside chat and investor meetings, accessible through a webcast on the Company's IR website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.43%
Tags
conferences
-
Rhea-AI Summary
Augmedix appoints Tomer Levy as Senior Vice President of Engineering to enhance product development and operational efficiency in healthcare technology sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.68%
Tags
none
Rhea-AI Summary
Augmedix, Inc. (AUGX) to participate in Maxim Group Virtual Healthcare IT Conference on January 24, 2024. Manny Krakaris, CEO, to join fireside chat with Allen Klee, Equity Research Analyst. Investors can arrange meetings through FNK IR or Maxim Group representative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
none
Augmedix

Nasdaq:AUGX

AUGX Rankings

AUGX Stock Data

116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
Link
United States
SAN FRANCISCO